EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Needle-Free Injection Enhances the Immunogenicity and Antitumor Efficacy of Whole-Cell Tumor Vaccines

Chin-Yang Chang iD, Yu-Diao Kuan iD, Jiayu A Tai, Nan Ju iD, Yen-Liang Li, Munehisa Shimamura iD

Vaccines · 27.04.2026 · 14 (5) · 392

DOI: 10.3390/vaccines14050392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 27.04.2026. Verfasst von Chin-Yang Chang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gene and Stem Cell Regenerative Therapeutics, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Whole-cell vaccines have demonstrated clinical potential in cancer treatment and recurrence prevention, yet their immunogenicity and dendritic cell (DC) activation remain suboptimal. This study aimed to evaluate whether a needle-free injector (NFI) could enhance the immunogenicity and antitumor efficacy of whole-cell tumor vaccines.

Methods

Adaptive immune responses induced by NFI and traditional syringe injection (SYI) were compared following whole-cell vaccine administration. The morphology of vaccine fluid ejected by NFI and SYI was examined, and the effects on DC antigen uptake and activation were assessed. Antitumor efficacy was further evaluated in MC38 colon adenocarcinoma challenge models.

Results

NFI administration elicited stronger antigen-specific adaptive immune responses than SYI. The high-velocity pressure generated by NFI resulted in fragmentation of whole-cell vaccine material, and this morphological alteration was associated with enhanced DC antigen uptake and activation. These immunological improvements corresponded with superior tumor suppression in MC38 models following NFI-delivered vaccination.

Conclusions

NFI delivery enhances the immunogenicity and antitumor efficacy of whole-cell tumor vaccines. These findings suggest that needle-free injectors may serve as a simple and effective strategy to improve the performance of whole-cell cancer vaccines.

Schlagwörter

Stichwörter der Autor:innen

antitumor immunitycancer immunotherapycancer vaccineneedle-free injectionwhole-cell tumor vaccine

Autor:innen und Institutionen

  • Department of Gene and Stem Cell Regenerative Therapeutics, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
  • Department of Device Application for Molecular Therapeutics, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
  • National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan.

ORCID-Profile: Chin-Yang Chang, Yu-Diao Kuan, Nan Ju, Munehisa Shimamura

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Chang, C. Y., Kuan, Y. D., Tai, J. A., Ju, N., Li, Y. L., & Shimamura, M. (2026). Needle-Free Injection Enhances the Immunogenicity and Antitumor Efficacy of Whole-Cell Tumor Vaccines. Vaccines, 14(5), 392. https://doi.org/10.3390/vaccines14050392

Vancouver

Chang CY, Kuan YD, Tai JA, Ju N, Li YL, Shimamura M. Needle-Free Injection Enhances the Immunogenicity and Antitumor Efficacy of Whole-Cell Tumor Vaccines. Vaccines. 2026;14(5):392. doi:10.3390/vaccines14050392

BibTeX
@article{Chang2026,
  author = {Chang, Chin-Yang and Kuan, Yu-Diao and Tai, Jiayu A and Ju, Nan and Li, Yen-Liang and Shimamura, Munehisa},
  title = {Needle-Free Injection Enhances the Immunogenicity and Antitumor Efficacy of Whole-Cell Tumor Vaccines},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {392},
  doi = {10.3390/vaccines14050392}
}
Kostenlos starten →